[ad_1] Image source: Getty Images When hunting for shares to buy, the moment everyone else loses interest is usually the time to start paying attention. And that’s definitely the case with oil stocks. The Kushner-Witkoff talks in Qatar have reopened…
[ad_1] Image source: Getty Images I don’t plan to work forever, so I invest in shares to eventually live off passive income from my portfolio. But how much does one need to target a large-enough cash stream in retirement? It…
[ad_1] Image source: Getty Images The FTSE 100 rarely rewards patience as quickly as it had with Informa (LSE: INF) this spring. The stock’s recovered from a 719p low to around 866p – a 20% gain in a matter of…
[ad_1] Image source: Getty Images With glorious weather, relaxing summer days and exciting sporting fixtures to watch, many people’s minds will be far from the stock market this month. At the start of January, some people began the year by…
[ad_1] One growth stock that’s on fire right now is trading and investment platform operator Robinhood Markets (NASDAQ: HOOD). Since the end of March, it’s gained about 50%. Looking ahead, I see potential for significant gains from here. Because not…
[ad_1] About two-thirds of my Stocks and Shares ISA is made up of growth shares. They’re a motley bunch, ranging from AI colossus Nvidia to sports nutrition firm Applied Nutrition from the FTSE 250. In June, a handful of these…
[ad_1] The BP (LSE: BP) share price is once again back below 500p, trading around 458p, as I write. That’s a sharp pullback from March, when it briefly traded above 600p. But with a price-to-earnings (P/E) ratio above 30, the…
[ad_1] Image source: Getty Images A Self-Invested Personal Pension (SIPP) is often the first account people consider when thinking about retirement. That makes sense, since the account is designed specifically for retirees (the word pension’s right there in the name).…
[ad_1] Image source: Getty Images There’s no better way to target long and lasting dividends than with FTSE 100 and FTSE 250 shares. That’s my view at least. UK blue-chip companies are famed for their strong balance sheets and robust…
[ad_1] Image source: Getty Images AstraZeneca’s (LSE: AZN) share price rose this week after after the EU approved Enhertu for adults with unresectable or metastatic HER2-positive solid tumours. In layman’s terms, that means the drug can now be sold in…